Prescribe Right
Prescribe Right
  • Home
  • About
    • Endorsements
    • Published Articles
    • Consulting
    • Effective Pharmacotherapy
  • Pipeline News
    • Podcast
    • Recent Tweets
  • Pharmaceutical Pipeline Tracker
    • Access Pharmaceutical Pipeline Tracker
    • Pharmaceutical Pipeline Tracker Demo
    • Sample Drug Review
    • Case Studies >
      • Monitoring Drugs With PDUFA Dates
      • Monitoring Drugs By Therapeutic Category
      • Monitoring by Indication
      • Research a Single Drug
    • Sample Searches >
      • Single Drug Report Sample
      • Indication Search Sample
      • Drug Class Search Sample
      • Therapeutic Area Search Sample
      • Company Search Sample
  • COVID-19
    • COVID-19 Updates
    • COVID-19 Vaccines
    • COVID-19 Antivirals
    • COVID-19 Monoclonal Antibodies
    • COVID-19 Plasma Products
    • COVID-19 Anti-Inflammatories
    • Remdesivir
    • Ivermectin
  • Contact Us
  • Home
  • About
    • Endorsements
    • Published Articles
    • Consulting
    • Effective Pharmacotherapy
  • Pipeline News
    • Podcast
    • Recent Tweets
  • Pharmaceutical Pipeline Tracker
    • Access Pharmaceutical Pipeline Tracker
    • Pharmaceutical Pipeline Tracker Demo
    • Sample Drug Review
    • Case Studies >
      • Monitoring Drugs With PDUFA Dates
      • Monitoring Drugs By Therapeutic Category
      • Monitoring by Indication
      • Research a Single Drug
    • Sample Searches >
      • Single Drug Report Sample
      • Indication Search Sample
      • Drug Class Search Sample
      • Therapeutic Area Search Sample
      • Company Search Sample
  • COVID-19
    • COVID-19 Updates
    • COVID-19 Vaccines
    • COVID-19 Antivirals
    • COVID-19 Monoclonal Antibodies
    • COVID-19 Plasma Products
    • COVID-19 Anti-Inflammatories
    • Remdesivir
    • Ivermectin
  • Contact Us

COVID-19 updates

Picture

COVID-19 Update #139 8/26/2022

8/26/2022

 
COVID-19 Vaccines
 
Pfizer and BioNTech have requested FDA an EUA for a bivalent vaccine, on 8/22/2022, containing the original Pfizer-BioNTech COVID-19 vaccine and a new Omicron BA.4/BA.5 variant vaccine. When approved, the companies are ready to start shipping the vaccine. Moderna requested an EUA for a similar bivalent vaccine a day later. Neither vaccine has any clinical trial data available, instead the NDA are based on preclinical and manufacturing data, as well as human studies of vaccines that incorporated the BA.1 omicron strain. The FDA authorized EUAs for bivalent vaccines from Moderna and Pfizer-BioNTech on 8/31/2022. The Moderna COVID-19 Vaccine is approved for patients 18 years and older. The Pfizer-BioNTech COVID-19 Vaccine, is approved for patients 12 years of age and older. The vaccines are given as a single booster dose at least two months following primary or booster vaccination. ACIP voted 13-1 to recommend the updated COVID-19 vaccine boosters, on 9/1/2022, and the CDC agreed and endorsed the vaccines the same day.
 
COVID-19 Antivirals
 
A review of data for 109,254 non-hospitalized, high-risk, COVID-19 patients found that use of nirmatrelvir reduced hospitalization in patients 65 and older (14.7 cases vs 58.9 cases per 100,000 person-days). However, in patients 40 to 64, there was no reduction (15.2 cases vs 15.8 cases per 100,000 person-days). Mortality was also reduced in older patients, but not in younger patients.

Comments are closed.
    Stay informed, subscribe to the Prescribe Right Pharmaceutical Pipeline Tracker

    Archives

    January 2023
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020

    Categories

    All

    RSS Feed

Services

Pharmaceutical Pipeline Tracker​
Consulting

Company

About
Blog
Tweets

Support

Contact
© COPYRIGHT 2015. ALL RIGHTS RESERVED.